Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis

Liqiu Kou, Chien-Jung Huang, Changyou Huang, Di Xiao, Songjie Liao, Yaling Li, Qing Wang
In: Obstetrical & Gynecological Survey · 2025 · vol. 80(11) , pp. 697–699 · doi:10.1097/ogx.0000000000001460 · PMID:41194364 · W4415946561
review OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This systematic review and meta-analysis evaluated pharmacologic interventions for endometriosis-related pain, synthesizing evidence on their effectiveness.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

(Abstracted from Obstet Gynecol 2025;146(2):e23-e35) An estimated 10% to 15% of women who are of reproductive age are affected by endometriosis, defined as abnormal growth of endometrium-like tissue outside of the uterus. Symptoms can include cyclical or noncyclical abdominal pain, pain during intercourse, excessive menstruation, infertility, and others.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK